Humacyte, Inc. (HUMA) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Humacyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Humacyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.45 M, a 19.6% decline year-over-year.
  • Humacyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $6.47 M, a 0.42% increase year-over-year.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.83 M, a 10.4% increase from 2022.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.18 M, a 39.1% decline from 2021.
  • Humacyte, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.1 M, a 116% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.47 M $1.45 M -$355 K -19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.83 M $1.41 M -$264 K -15.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $7.09 M $1.77 M +$296 K +20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.8 M $1.84 M +$350 K +23.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $6.45 M $1.81 M +$262 K +16.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $6.18 M $1.67 M -$1.14 M -40.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $7.33 M $1.48 M -$401 K -21.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.73 M $1.49 M -$1.44 M -49.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $9.17 M $1.55 M -$981 K -38.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $10.1 M $2.81 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $1.88 M +$707 K +60.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.93 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.53 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $1.17 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.